Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Citrin

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Prostate|January 1, 1991
A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trialD L Citrin, M I Resnick, P Guinan, et al.
The British Journal of Surgery|September 1, 1978
The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancerJ H McKillop, L H Blumgart, C B Wood, et al.
Cancer|February 15, 1981
The use of serial bone scans in assessing response of bone metastases to systemic treatmentD L Citrin, C Hougen, W Zweibel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancerF R Ahmann, D L Citrin, H A deHaan, et al.
Surgery|December 1, 1991
Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinomaR A Decker, P Elson, T F Hogan, et al.
Archives of Internal Medicine|May 1, 1987
Clodronate. A randomized study in the treatment of cancer-related hypercalcemiaR S Witte, J Koeller, T E Davis, et al.
Breast Cancer Research and Treatment|October 18, 2012
Phase II open-label study of sunitinib in patients with advanced breast cancerDenise A Yardley, E Claire Dees, Stephen D Myers, et al.
Archives of Internal Medicine|May 1, 1987
Maintenance etidronate in the prevention of malignancy-associated hypercalcemiaJ H Schiller, P Rasmussen, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2008
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapyStephen Johnston, Maureen Trudeau, Bella Kaufman, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Prostate|January 1, 1991
A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trialD L Citrin, M I Resnick, P Guinan, et al.
The British Journal of Surgery|September 1, 1978
The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancerJ H McKillop, L H Blumgart, C B Wood, et al.
Cancer|February 15, 1981
The use of serial bone scans in assessing response of bone metastases to systemic treatmentD L Citrin, C Hougen, W Zweibel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancerF R Ahmann, D L Citrin, H A deHaan, et al.
Surgery|December 1, 1991
Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinomaR A Decker, P Elson, T F Hogan, et al.
Archives of Internal Medicine|May 1, 1987
Clodronate. A randomized study in the treatment of cancer-related hypercalcemiaR S Witte, J Koeller, T E Davis, et al.
Breast Cancer Research and Treatment|October 18, 2012
Phase II open-label study of sunitinib in patients with advanced breast cancerDenise A Yardley, E Claire Dees, Stephen D Myers, et al.
Archives of Internal Medicine|May 1, 1987
Maintenance etidronate in the prevention of malignancy-associated hypercalcemiaJ H Schiller, P Rasmussen, A B Benson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2008
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapyStephen Johnston, Maureen Trudeau, Bella Kaufman, et al.
Pageof 4